Biologicals - World Health Organization (WHO)
5 天之前 · Biological therapeutics, also referred to as Biologicals, are those class of medicines which are grown and then purified from large-scale cell cultures of bacteria or yeast, or plant or animal cells. Biologicals are a diverse group of medicines which includes vaccines, growth factors, immune modulators, monoclonal antibodies, as well as ...
Biological weapons - World Health Organization (WHO)
2018年9月6日 · Biological weapons form a subset of a larger class of weapons sometimes referred to as unconventional weapons or weapons of mass destruction, which also includes chemical, nuclear and radiological weapons. The use of biological agents is a serious concern, and the risk of using these agents in a terrorist attack is thought to be increasing.
Guidelines for Biologicals - World Health Organization (WHO)
2004年11月19日 · Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks, Annex 3, TRS No 978. 6 November 2015.
Biotherapeutic products - World Health Organization (WHO)
Biotherapeutic products. Biotechnology describes biological processes that have been manipulated or modified in some way through modern science. A major industrial application of biotechnology is in the development and preparation of biological medicinal products using genetically engineered bacteria, yeast, fungi, cells or even whole animals ...
Determinants of health - World Health Organization (WHO)
2024年10月4日 · These determinants—or things that make people healthy or not—include the above factors, and many others: Income and social status - higher income and social status are linked to better health. The greater the gap between the richest and poorest people, the greater the differences in health. Education – low education levels are linked with ...
Laboratory biosafety manual, 4th edition - World Health …
2020年12月21日 · This fourth edition of the manual builds on the risk assessment framework introduced in the third edition. A thorough, evidence-based and transparent assessment of the risks allows safety measures to be balanced with the actual risk of working with biological agents on a case-by-case basis. This novel evidence- and risk-based approach will ...
Connecting global priorities: biodiversity and human health: a …
2015年6月3日 · They also limit disease and stabilize the climate. But biodiversity loss is happening at unprecedented rates, impacting human health worldwide, according to a new state of knowledge review of the Convention on Biological Diversity (CBD) and WHO. The report synthesizes the available information on the most important inter-linkages between ...
Anxiety disorders - World Health Organization (WHO)
2023年9月27日 · Anxiety disorders, like other mental health conditions, result from a complex interaction of social, psychological and biological factors. Anyone can have an anxiety disorder, but people who have lived through abuse, severe losses or other adverse experiences are more likely to develop one.
rogeneity from one preparation and/or batch to the next. Consequently, special considerations are needed when manufacturing biological prod. cts in order to maintain consistency in product quality.Good manufacturing practices (GMP) for bio. ogical products were first published by WHO in 1992 (1). This current revision reflects subsequent ...
Safeguarding biosafety and biosecurity in laboratories
2019年12月11日 · With the occurrence of a potential, suspected or confirmed deliberate biological event, WHO would, upon the invitation of the affected Member State(s), work closely with the Member State government(s), other UN agencies, and other international partners as appropriate, support the event response, and assess and mitigate the public health consequences.